K-ras mutations are thought to be an early event in colorectal neoplasia [1] and are observed in 9–10 % of small adenomas, in 40–50 % of large adenomas and in 40–65 % of colon carcinomas [24]. The gene discussed is KRAS; the disease is colon carcinoma.